Advertisement

  1. National

Prostate cancer drug approved

The National Institute for Health and Clinical Excellence (Nice) has revised its recommendations on a drug to treat advanced prostate cancer.

The institute now says Abirateron, marketed as Zytiga, should be given to patients on the NHS.

View all 4 updates ›

Prostate cancer drug approved

Prostate cancer cells seen through a coloured scanning electron micrograph (SEM)

A drug to treat advanced prostate cancer should be given to patients on the NHS, a health watchdog has said.

Abirateron, marketed as Zytiga, can extend the lives of late-stage cancer sufferers by more than three months.

The National Institute for Health and Clinical Excellence (Nice) revised its recommendations after fresh information from manufacturer Janssen, and the new draft guidance was welcomed by experts.

More top news